الموقع الشخصي

#	title
1	Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase
2	Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase
3	Bioinformatics, enzymologic properties, and comprehensive tracking of Plasmodium falciparum nucleoside diphosphate kinase.
4	Bioinformatics, enzymologic properties, and comprehensive tracking of Plasmodium falciparum nucleoside diphosphate kinase.
5	Bioinformatics, enzymologic properties, and comprehensive tracking of Plasmodium falciparum nucleoside diphosphate kinase.
6	Bioinformatics, enzymologic properties, and comprehensive tracking of Plasmodium falciparum nucleoside diphosphate kinase.
7	The Protective Effects of Nigella sativa Oil and Allium sativum Extract on Amikn cm-induced Nephrotoxicity.
8	The Protective Effects of Nigella sativa Oil and Allium sativum Extract on Amikn cm-induced Nephrotoxicity.
9	The exceptional properties of Plasmodium deoxyguanylate pathways as a potential area for metabolic and drug discovery studies
10	The exceptional properties of Plasmodium deoxyguanylate pathways as a potential area for metabolic and drug discovery studies
11	The exceptional properties of Plasmodium deoxyguanylate pathways as a potential area for metabolic and drug discovery studies
12	Substrate specificity and nucleotides binding properties of NM23H2/nucleoside diphosphate kinase homolog from Plasmodium falciparum
13	Substrate specificity and nucleotides binding properties of NM23H2/nucleoside diphosphate kinase homolog from Plasmodium falciparum
14	The substrate binding preferences of Plasmodium thymidylate kinase
15	The substrate binding preferences of Plasmodium thymidylate kinase
16	Binding dynamics and energetic insight into the molecular forces driving nucleotide binding by guanylate kinase
17	Binding dynamics and energetic insight into the molecular forces driving nucleotide binding by guanylate kinase
18	Thymidylate kinase: the lost chemotherapeutic target
19	Thymidylate kinase: the lost chemotherapeutic target
20	Thymidylate kinase: the lost chemotherapeutic target
21	Thymidylate kinase: the lost chemotherapeutic target
22	Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats.
23	Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats.
24	Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats.
25	Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats.
26	Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats.
27	Macromolecular interactions of spectinomycin with Bovine serum albumin
28	Macromolecular interactions of spectinomycin with Bovine serum albumin
29	Macromolecular interactions of spectinomycin with Bovine serum albumin
30	Analysis of the molecular interactions and complexation of chloroquine with bovine serum albumin
31	Analysis of the molecular interactions and complexation of chloroquine with bovine serum albumin
32	Carbocyclic thymidine derivatives efficiently inhibit< i> Plasmodium falciparum thymidylate kinase (< i> Pf TMK)
33	Carbocyclic thymidine derivatives efficiently inhibit< i> Plasmodium falciparum thymidylate kinase (< i> Pf TMK)
34	Carbocyclic thymidine derivatives efficiently inhibit< i> Plasmodium falciparum thymidylate kinase (< i> Pf TMK)
35	Carbocyclic thymidine derivatives efficiently inhibit< i> Plasmodium falciparum thymidylate kinase (< i> Pf TMK)
36	Carbocyclic thymidine derivatives efficiently inhibit< i> Plasmodium falciparum thymidylate kinase (< i> Pf TMK)
37	Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3?-overhang region
38	Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3?-overhang region
39	Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3?-overhang region
40	Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3?-overhang region
41	Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3?-overhang region
42	Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing
43	Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing
44	In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference
45	In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference
46	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
47	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
48	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
49	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
50	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
51	Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
52	Efficacy of amprolium and toltrazuril in chicken with subclinical infection of cecal coccidiosis
53	Current and future asthma therapies.
54	Current and future asthma therapies.
55	Current and future asthma therapies.
56	Current and future asthma therapies.
57	Effect of Amlodipine and Trimetazidine on Gentamicin-Induced Nephrotoxicity in Rats
58	Effect of Amlodipine and Trimetazidine on Gentamicin-Induced Nephrotoxicity in Rats
59	Chelating efficiency and mechanisms of interaction of some toxic and biologically important cations with EDTA by isothermal titration calorimetry
60	Chelating efficiency and mechanisms of interaction of some toxic and biologically important cations with EDTA by isothermal titration calorimetry
61	Chelating efficiency and mechanisms of interaction of some toxic and biologically important cations with EDTA by isothermal titration calorimetry
62	Chelating efficiency and mechanisms of interaction of some toxic and biologically important cations with EDTA by isothermal titration calorimetry
63	Chelating efficiency and mechanisms of interaction of some toxic and biologically important cations with EDTA by isothermal titration calorimetry
64	Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
65	Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
66	Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
67	Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
68	Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
69	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
70	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
71	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
72	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
73	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
74	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
75	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against< i> Plasmodium falciparum thymidylate kinase
76	Facile synthesis of 1?, 2?-< i> cis-$beta$-pyranosyladenine nucleosides
77	Facile synthesis of 1?, 2?-< i> cis-$beta$-pyranosyladenine nucleosides
78	Facile synthesis of 1?, 2?-< i> cis-$beta$-pyranosyladenine nucleosides
79	Facile synthesis of 1?, 2?-< i> cis-$beta$-pyranosyladenine nucleosides
80	Facile synthesis of 1?, 2?-< i> cis-$beta$-pyranosyladenine nucleosides
81	Bioinformatics analysis of the recent MERS-CoV with special reference to the virus-encoded Spike protein
82	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
83	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
84	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
85	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
86	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
87	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
88	Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase